FDA Approved: ZEPOSIA 7-DAY STARTER PACK — Supplemental Application (Celgene Corporation)

View source ↗

Summary

The FDA approved a supplemental application to introduce a 7-day starter pack of Zeposia (ozanimod hydrochloride) for Celgene Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Forms of Multiple Sclerosis
• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

SUPPL AP for ZEPOSIA 7-DAY STARTER PACK (OZANIMOD HYDROCHLORIDE)